Dr. Gary S Brandwein D.O.

Recommended Articles

• What Is Oromandibular Dystonia?

  Oromandibular DystoniaOromandibular dystonia is a type of focal dystonia. This condition is also called cranial dystonia, in which the face, jaw, or tongue forcefully contracts and becomes difficult to open and close the mouth. Thus, a person's speech and ability to chew are affected. Cranial...

• Immunosuppressive Drugs for Multiple Sclerosis

  What is multiple sclerosis (MS)?Multiple sclerosis is a medical condition that affects the brain and the spinal cord. A few of the early symptoms of the disease are numbness, tingling sensation, blurry vision, and feeling weak. In this disease, the immune system tends to attack the myelin, which is...

• Jillian Mercado Slays It on Beyoncé's Clothing Campaign

  A couple of years ago Jillian Mercado, the 27-year-old New Yorker, was beginning to stand out as a fashion reference; she managed her own blog and jumped to fame for being the image of the Diesel and Nordstrom brands.And, soon after, Beyoncé, yes the Queen B, has chosen her to be the face of her...

• Ehlers-Danlos Syndrome: Symptoms, Causes, Diagnosis, and Treatment

  What is Ehlers-Danlos syndrome (EDS)?Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the body’s connective tissues, which are proteins that support the blood vessels, skin, bones, and other organs in the body. Connective tissues also provide elasticity and strength to the...

• Is Obsessive Compulsive Disorder Common Among Muscular Dystrophy Patients?

  Researchers have discovered that, compared to the general public, there is a higher than average rate of obsessive-compulsive disorder (OCD) in those with Duchenne Muscular Dystrophy (DMD). Researchers from the University of Iowa conducted and published research in the May 2018 issue of The Journal...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...